Refine by
Medications For Acute Treatment Articles & Analysis
175 news found
TannerMedico A/S has received the highest credit rating – AAA – only awarded to financially strong and stable companies. This recognition confirms our solid foundation and our ability to establish long-term, reliable partnerships. As the manufacturer of Asonor®, a CE-marked Class IIa medical device for the treatment of snoring, we offer a well-documented product with: 20+ ...
TannerMedico A/S has received the highest credit rating – AAA – only awarded to financially strong and stable companies. This recognition confirms our solid foundation and our ability to establish long-term, reliable partnerships. As the manufacturer of Asonor®, a CE-marked Class IIa medical device for the treatment of snoring, we offer a well-documented product with: 20+ ...
Klebsiella is described by the Centers for Disease Control and Prevention (CDC) as a type of gram-negative bacteria that can cause different types of healthcare-associated infections (HAIs). These include pneumonia, bloodstream infections, wound or surgical site infections, and meningitis. Klebsiella are normally found in the human intestines (where they do not cause disease), and also in human ...
Asthma and Allergy Awareness Month is just a few weeks away, and this year, the 6th of May is recognized as World Asthma Day. The month of May is dedicated to asthma control and education to increase awareness about the disease and how those with it can prevent or mitigate exposures to asthma triggers, allergens, and respiratory irritants. Asthma is one of the most common lifelong chronic ...
Medical science is witnessing remarkable advancements in neurology and oncology, with cutting-edge technologies shaping the future of patient care. Transcranial techniques are improving neurological diagnostics, while tumor tissue-based technology is revolutionizing cancer treatment, particularly in prostate cancer screening. In dermatology, new methods for treating benign epidermal lesions are ...
In the rapidly evolving landscape of pharmaceutical innovations, CD Formulation emerges as a key player, offering customized drug conjugates services that cater to the rising demands for advanced drug development. Specializing in complex biologic formulations, Biologics & Biosimilars service team of CD Formulation is revolutionizing how drug conjugate products are conceptualized and produced, ...
Alfa Chemistry, a recognized leader in the alkaloid industry, has expanded its offerings to include a comprehensive range of alkaloids-related natural products. This expansion underscores its commitment to providing high-quality compounds for various applications in medicine, food, and cosmetics. The suite of products now includes saccharides, flavonoids, terpenoids, phenylpropanoids, ...
Huateng Pharma, a distinguished provider of premium pharmaceutical intermediates, proudly unveils its latest breakthrough: Semaglutide Side Chain. This groundbreaking addition to Huateng Pharma's esteemed portfolio signifies a remarkable leap forward in pharmaceutical innovation, showcasing a diverse array of compounds including AEEA-AEEA (CAS NO.: 1143516-05-5), SNAC (CAS NO.: 203787-91-1), ...
In the complex landscape of medical waste management, the importance of effective treatment methods cannot be overstated. Refractory materials play a crucial role in facilitating safe and efficient processes for the incineration and disposal of medical waste. In this article, we explore the significance of refractory materials in medical waste treatment and their contribution to maintaining ...
Dr. Ali Tinazli's post at the Forbes magazine about "History Of Health Technologies And Meaningful Change In The Era Of Health 4.0" The medicine in ancient Egypt is some of the oldest in history. Although rudimentary, it was already highly personalized and with exclusive access. During the Renaissance—one of the most remarkable ages of humankind—medicine ...
xCures, Inc. is proud to announce their partnership with RenovoRx, a clinical-stage biopharmaceutical company that focuses on fighting cancer through localized treatment of difficult-to-treat tumors, such as pancreatic adenocarcinoma. Through this collaboration, xCures will help eligible pancreatic cancer patients access a Phase III clinical study entitled, Targeted Intra-arterial Gemcitabine vs. ...
ByxCures
Targeting peak sales potential of $1 billion in the major markets Destiny Pharma plc (AIM: DEST), a clinical stage innovative biotechnology company focused on the development of novel medicines that can prevent life-threatening infections, is pleased to announce that it has now finalised plans for its Phase 3 studies for its late-stage clinical asset, XF-73 Nasal. Highlights Discussions held ...
Coralville, Iowa December 7, 2022 — Digital Diagnostics – a leading AI diagnostics company on a mission to transform global healthcare – is a recipient of CB Insights’ fourth-annual Digital Health 150. The list recognizes the 150 most promising private digital health companies of 2022. “From reimagining clinical care, to leveraging tech like AR/VR to improve ...
Lumen Bioscience—a clinical-stage biopharmaceutical company developing biologic drugs for highly prevalent diseases—today announced the receipt of a $3.6 million award from the Department of Defense (DoD) for advanced biomedical product development in support of Naval operations. The award from the Medical Technology Consortium (MTEC), a 501(c)(3) biomedical technology consortium ...
xCures, a Real-Time Regulatory Grade Clinical Data (RRC) platform, will be joining Aetion, a global real-world evidence software and analytics provider, and a group of leading diverse partners in Aetion’s launch of the Coalition for the Advancement of RWE through Randomized Controlled Trial Emulation (CARE) Initiative. Aetion’s initiative will focus on better understanding the ...
ByxCures
iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading cardiovascular diagnostics and digital healthcare solutions company focused on creating trusted solutions that detect, predict, and prevent disease, today announced a new health economic analysis of the mSToPS study, presented at the American Heart Association’s 2022 Scientific Sessions event. The study, titled “Cost-Effectiveness ...
Today, xCures announced that they will present two posters at the 27th Annual Meeting of the Society for Neuro-Oncology, from the 16th to the 20th of November 2022, in Tampa Bay, Florida. The Society for Neuro-Oncology is a multidisciplinary society of healthcare professionals dedicated to promoting advances in neuro-oncology through research and education. Their annual meeting features research ...
ByxCures
Last month, the 21st Century Cures Act forced healthcare organizations to provide patients quick and easy access to their health records in a digital format. In response to the news, xCures is happy to announce that patients using their platform, can now automatically retrieve their medical records from the institutions where they received care, and get instant access to a powerful care ...
ByxCures
Profacgen, a biotechnology company that offers bioinformatics platform to help academic and industrial researchers to explore, understand and analyze complex biological data in various biotechnological programs and projects, recently updated its in silico protein-protein interactions prediction service to meet diversified needs of its customers. As one of the most common molecules in cells, ...
BTL, the authority in non-invasive facial and body sculpting therapies, has announced the return of the BTL SCHOLAR DRAFT – an annual program that grants five student-athletes $15,000 each for their college tuition. This year, BTL has partnered with renowned professional golfer Michelle Wie West to promote the BTL SCHOLAR DRAFT and select the winners. The program officially kicked off on ...